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Abstract
Recent evidence indicates that peroxynitrite represents a major cytotoxic effector in heart diseases,
but its mechanisms of action are still not known exactly. Notably, the ability of peroxynitrite to trigger
cardiomyocyte apoptosis, a crucial mode of cell death in many cardiac conditions, remains poorly
defined. We evaluated apoptotic and necrotic cell death in cultured H9C2 cardiomyocytes, following
a brief (20 min) exposure to peroxynitrite (50–500 μM). Peroxynitrite-dependent myocardial toxicity
was then investigated in a rat model of myocardial ischemia-reperfusion (MIR), where the effects of
peroxynitrite were blocked by the superoxide dismutase mimetics and peroxynitrite scavenger Mn
(III)-tetrakis(4-benzoic acid) porphyrin (MnTBAP). In vitro, peroxynitrite killed cardiomyocytes
mostly through apoptosis (DNA fragmentation, apoptotic nuclear alterations, caspase-3 activation,
and PARP cleavage), but not necrosis (propidium iodide staining and LDH release). In vivo, MIR
triggered myocardial oxidative stress (malondialdehyde generation), nitrotyrosine formation,
neutrophil accumulation, and the cleavage of caspase-3 and PARP, indicating ongoing myocardial
apoptosis. MnTBAP suppressed these alterations, allowing a considerable reduction of myocardial
injury. Thus, peroxynitrite triggers apoptosis in cardiomyocytes in vitro and in the myocardium in
vivo, through a pathway involving caspase-3 activation and the cleavage of PARP. These results
provide important novel information on the mechanisms of myocardial toxicity of peroxynitrite.
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Introduction
Peroxynitrite (ONOO−) is a strong biological oxidant and nitrating species formed from the
near-diffusion-limited reaction of the free radicals nitric oxide and superoxide anion [1].
ONOO− formation represents a major mechanism of myocardial injury in various cardiac
pathologies including myocardial infarction, chronic heart failure, and cardiomyopathy
associated with anthracyclines, diabetes, septic, and hemorrhagic shock (see [2,3] for recent
reviews). The myocardial cytotoxicity of ONOO− involves direct oxidative damage to lipids,
proteins, and DNA [3], the activation of metalloproteinases [4], and the nitration of tyrosine
residues within proteins [3,5]. We also provided evidence that ONOO− acts as a potent
signaling molecule in cardiomyocytes, activating all members of the MAP kinase family [6],
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and inhibiting the activation of the transcription factor nuclear factor kappa B [7]. Furthermore,
a major pathway of ONOO− dependent myocardial cytotoxicity relies on oxidative DNA
damage and activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) [8], which
consumes cellular nicotinamide dinucleotide (NAD) and adenosine triphosphate (ATP),
leading to cell necrosis [8,9]. Indeed, the prevention of PARP activation markedly reduces cell
necrosis in many different cell systems in vitro [10] as well as in various animal models of
diseases in vivo, notably myocardial infarction [11,12].
In contrast to its role in cell necrosis, the role of ONOO− in triggering cardiomyocyte apoptosis
has been poorly investigated. Apoptosis is orchestrated by the proteolytic activation of cysteine
proteases known as caspases and regulated by proteins belonging to the bcl-2 family. Distinct
pathways of apoptosis converge to the activation of executioner caspase-3, which cleaves
multiple downstream cellular targets [13]. An important target of caspase-3 is PARP, whose
cleavage and inactivation maintains the cellular ATP stores indispensable for apoptosis to
proceed properly [14]. Recent evidence has emerged that apoptosis is an important mechanism
of cardiomyocyte cell death in conditions such as myocardial reperfusion, cardiomyopathy,
and heart failure [15,16]. Such conditions are also associated with enhanced ONOO−
generation and myocardial oxidative stress, which may represent an important mechanism in
the development of myocardial apoptosis [16]. So far, only one in vitro study reported that
exposure of cardiomyocytes to ONOO− resulted in apoptotic cell death, via an increased
expression of the proapoptotic protein Bax [17], and there is no information regarding the
potential proapoptotic role of ONOO− in vivo. The present study addressed these issues, using
both in vitro and in vivo approaches. The mechanisms of ONOO− mediated cytotoxicity were
first determined in cultured rat cardiomyocytes (H9C2 cells) exposed to authentic ONOO−.
Secondly, these mechanisms were assessed in an in vivo model of rat myocardial infarction,
where the effects of ONOO− were inhibited by Mn(III)-tetrakis(4-benzoic acid) porphyrin
chloride (MnTBAP), a stable and cell-permeable superoxide dismutase mimetic and
ONOO− scavenger [18,19]. Our data show that ONOO− exerts potent proapoptotic effects in
cardiomyocytes in vitro and in the myocardium in vivo, characterized by the activation of
caspase-3 and the cleavage of PARP. Thus, ONOO− may represent a major effector of
cardiomyocyte apoptosis contributing to myocardial damage and dysfunction in a wide range
of cardiac pathologies.
Materials and methods
In vitro experiments
Cell culture conditions and stimulation with ONOO−—H9C2 cells, a clonal line
derived from rat heart (ATCC, Manassas, VA), were grown (5% CO2, 37°C) in DMEM (Gibco
BRL, Invitrogen, Basel, Switzerland ) supplemented with 10% FBS, 100 units/ml penicillin,
and 0.1 mg/ml streptomycin. H9C2 cells are morphologically similar to embryonic cardiocytes
and are recognized as a well-suited model for the study of cardiomyocyte biology [20]. In
addition, we recently reported that ONOO− activated similar stress signaling responses in
H9C2 cells and primary murine cardiomyocytes [6]. ONOO− (obtained from Calbiochem) was
synthesized from isoamyl nitrite and hydrogen peroxide followed by removal of hydrogen
peroxide over a manganese dioxide column, as described [21], and was stored in 0.4 M NaOH
at −80°C. Prior to experimentation, the concentration of ONOO− was determined from its
absorption at 302 nm (extinction coefficient=1670 M−1 cm−1). Stimulation with ONOO− was
made in phosphate-buffered saline to avoid reactions of ONOO− with media constituents [6,
7]. ONOO− was delivered as a single bolus at a 1:100 dilution, at final concentrations of 50–
500 μM, in agreement with previous studies from our laboratory [6,7] and others [22,23]. Cells
were exposed to authentic ONOO− or decomposed ONOO− (DP, control condition) for 20 min,
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as previously described [6,7], after which they were replaced in complete culture medium for
the indicated times.
Cytotoxicity assays—Cell viability was assessed by measuring the mitochondrial-
dependent reduction of MTT (3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
to formazan, as described [24]. The amount of formazan formed was quantified by measuring
the absorbance of the solution at 540 nm.
The release of LDH in the culture medium was determined as an indicator of cell necrosis
[25,26], using a commercially available kit (Roche Molecular Biochemicals, Basel,
Switzerland), as per manufacturer’s protocol.
Nuclear morphology by fluorescence microscopy—The fluorescent nuclear binding
dyes Hoechst 33342 (Calbiochem), which readily enters cells with intact or damaged
membranes and stains DNA blue, and propidium iodide (PI, Sigma Chemicals), which is
impermeable to cells with preserved membranes and stains DNA red, were used to detect
necrotic and apoptotic cells. Both dyes were added (10 μg/ml, 20 min) to the cells 6 h after a
20-min exposure to ONOO−. Cells were then fixed in 4% paraformaldehyde and nuclear
morphology was visualized under a Zeiss fluorescence microscope. Apoptotic cells were
detected by typical nuclear morphological changes (chromatin condensation and nuclear
fragmentation), whereas necrotic cells were detected by intact nuclei and positive PI staining.
In addition, cells at a late stage of apoptosis, where the cell membrane integrity is lost, were
detected by typical apoptotic nuclei together with positive PI staining (“secondary” necrosis)
[27,28].
Evaluation of apoptosis—Apoptosis was evaluated as follows.
a. Quantification of DNA fragmentation: The Cell Death Detection ELISA kit (Roche
Molecular Biochemicals, Basel, Switzerland) was employed to quantify DNA
fragmentation on the basis of antibody detection of free histone and fragmented DNA,
according to the manufacturer’s instruction and previously published protocols [29];
b. Nuclear morphology (see above);
c. Immunoblot detection of cleaved caspase-3 and cleaved PARP.
After stimulation, cells were scraped in lysis buffer (TrisHCl 10 mM, NP40 0.5%, NaCl 0.15
M, Na3VO4 1 mM, NaF 10 mM, PMSF 1 mM, EDTA 1 mM, aprotinin 10 μg/ml, leupeptin
10 μg/ml, and pepstatin 1 μg/ml). Proteins (20 μg) were separated by SDS-PAGE, transferred
to nitrocellulose membrane, and blocked for 1 h at room temperature with 5% nonfat dry milk
in Tris-buffered saline containing 0.1% Tween 20. The membrane was incubated overnight at
4°C with an appropriate dilution of anti-caspase-3 (full-length, 33 kDa), anti-cleaved caspase-3
(17- to19-kDa fragments), anti-PARP-1 (119 kDa), and cleaved-PARP-1 (89 kDa) (all from
Cell Signaling, Beverly, MA) primary antibodies, followed by incubation for 1 h with a 1:5000
dilution of the appropriate horseradish peroxidase-conjugated secondary antibody (Bio-Rad,
Hercules, CA).
In vivo experiments
Surgical procedure—All procedures were in accordance with the Swiss laws on animal
experimentation and conformed with the principles outlined in the Declaration of Helsinki.
Myocardial ischemia-reperfusion was induced as described previously [11]. Briefly, adult male
Wistar rats (300–350 g) were anesthetized with intraperitoneal thiopentone sodium (60 mg
kg−1), tracheostomized, and mechanically ventilated (75 strokes min−1, tidal volume = 8 ml
kg−1, inspired fraction of oxygen=0.21) using a Harvard Model 683 rodent respirator (Harvard
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Apparatus, Holliston, MA). Core temperature measured via a rectal probe was maintained at
37°C. Following a left thoracotomy at the fourth intercostal space, the pericardium was opened
and the left anterior descending (LAD) coronary artery was ligated just below the left atrial
appendage by an intramural 5.0 silk suture and a snare occluder. Immediate palor of the left
ventricular free wall was indicative of successful occlusion. After 45 min of myocardial
ischemia, reperfusion was allowed for 2 h by removing the coronary occluder.
Rats exposed to ischemia and reperfusion were randomly assigned to treatment with MnTBAP
(Sigma Chemicals), 1 mg/kg given 20 min before reperfusion, 30 and 60 min after reperfusion
(intraperitoneally), or vehicle only (isotonic saline, 1 ml). The dose of MnTBAP was chosen
on the basis of previous experiments showing that MnTBAP at 1 mg/kg was efficient to reduce
the consequences of zymosan-induced shock in the rat [30].
Determination of myocardial infarct size—Area at risk (AAR) and infarct size were
determined using the triphenyltetrazolium chloride (TTC)-Evans blue technique, as described
[11]. The area at risk and the infarcted area were expressed as percentage values according to
conventional methods (AAR/left ventricle and infarcted area/AAR).
Myeloperoxidase assay (MPO)—MPO activity was determined in cardiac tissue
homogenates, using tetramethylbenzidine and hydrogen peroxide, as described [31]. Activity
was measured spectrophotometrically as the change in absorbance at 650 nm at 37°C, using a
Spectramax microplate reader (Molecular Devices, Sunnyvale, CA). Results are expressed as
units of MPO activity per gram protein (Bradford assay).
Malondialdehyde assay—Malondialdehyde formation was utilized to quantify lipid
peroxidation in heart tissue and measured as thiobarbituric acid-reactive material, as described
[31]. The levels of MDA are expressed as nanomole MDA per milligram protein.
Protein extraction and immunoblot detection of nitrotyrosine, cleaved
caspase-3, and cleaved PARP—Heart tissue was homogeneized (50 mg/ml) in lysis
buffer (TrisHCl 10 mM, NP40 0.5%, NaCl 0.15 M, Na3VO4 1 mM, NaF 10 mM, PMSF 1 mM,
EDTA 1 mM, aprotinin 10 μg/ml, leupeptin 10 μg/ml, and pepstatin 1 μg/ml). Western
immunoblotting (30 μg myocardial proteins) was performed as described above, using
appropriate dilutions of anti-caspase-3, anti-cleaved caspase-3, anti-PARP-1, anti-cleaved-
PARP-1 (Cell Signaling), and mouse monoclonal anti-nitrotyrosine (Cayman Chemical, Ann
Arbor, MI) primary antibodies. The immunoblot signal was visualized using enhanced
chemiluminescence (ECL, Amersham Biosciences, Otelfingen, Switzerland). Densitometric
analysis of ECL autoradiographs was performed using a Personal Densitometer and TotalLab
Software.
Presentation of data and statistical analysis—All graphs present data as means± SE.
For in vitro experiments, statistical analysis was performed using ANOVA followed by
Dunnett’s test to compare the effects of various concentrations of ONOO− with respect to
control conditions. In vivo data were analyzed with ANOVA followed by Bonferroni
adjustments for all pairwise comparisons, except from area at risk and infarct size which were
analyzed with Student’s t test.
Results
Cytotoxicity of ONOO− in cultured cardiomyocytes
ONOO− reduces H9C2 viability—As illustrated in Fig. 1, ONOO− moderately, but
significantly, reduced cell viability 4 h after stimulation (Fig. 1A), at concentrations of 100–
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500 μM. At 6 h poststimulation (Fig. 1B), the decrease in cell viability was much more
pronounced, an effect that was significant at all concentrations of ONOO− tested. DP did not
have any effect on cell survival.
Apoptotic and necrotic cell death elicited by ONOO−—At 6 h post ONOO−
stimulation, there was a 2-fold increase in LDH release in the medium of cells treated with 250
and 500 μM ONOO−, whereas no significant increase of LDH release was detected in cells
exposed to DP and to ONOO− at 50 and 100 μM (Fig. 1C). As illustrated in Fig. 1D, a marked
increase in DNA fragmentation was detected 6 h after treatment with ONOO− at all
concentrations tested. Hoechst 33342 staining clearly indicated that ONOO− induced nuclear
morphological changes typical of apoptosis, an effect that was most pronounced in cells treated
with 500 μM ONOO− (Fig. 2). Several cells with typical apoptotic nuclei also stained positive
with PI, which indicates that these cells were at a late stage of apoptosis (“secondary necrosis”),
where membranes become permeable to PI [27]. In comparison to apoptotic cell death, necrosis
appeared much less pronounced, as only a few cells disclosed morphologically normal nuclei
positively stained with PI. Overall, these data indicate that ONOO− induced both apoptosis
and necrosis in H9C2 cardiomyocytes, with apoptosis representing the preferred mode of cell
demise in the conditions of our study.
ONOO− triggers the cleavage of caspase-3 and PARP in H9C2 cells—Further
substantiating the proapoptotic role of ONOO− in H9C2 cells, ONOO− (but not DP) markedly
activated the cleavage of caspase-3 at 4 and 6 h after stimulation at all concentrations tested
(Fig. 3). We did not notice any significant change in the expression levels of procaspase-3 in
all the conditions. In addition to caspase-3 cleavage, ONOO− also activated the cleavage of
PARP, a well-known substrate of caspase-3, at 4 and 6 h, an effect concomitant to a decrease
in the expression levels of full-length PARP (Fig. 3). After 4 h, this effect was noted at 250
and 500 μM (and, to a lesser extent, at 100 μM), while at 6 h poststimulation, all concentrations
of ONOO− clearly induced the cleavage of PARP. In contrast to the effects of authentic
ONOO−, DP did not induce the cleavage of PARP and did not affect the expression levels of
full-length PARP.
Cytotoxicity of ONOO− in the myocardium in vivo
Reduction of infarct size by MnTBAP, an ONOO− scavenger—As shown in Fig. 4A,
the area at risk was comparable between the two groups of rats (in % of the left ventricle:
control group 47±4%, MnTBAP group 43±4%, P=0.42, t test). Infarct size was markedly and
significantly reduced in the animals treated with MnTBAP (in % of the AAR: control group
43±7%, MnTBAP group 13±4%, P=0.0026, t test; in % of the left ventricle: control group, 21
±4%, MnTBAP group 5±1%, P=0.0067, t test). Fig. 4B presents sections (mid left ventricles)
of hearts stained with Evans blue and TTC, which illustrate the reduction of infarct size
produced by MnTBAP.
MnTBAP reduces myocardial oxidative stress and neutrophil infiltration—When
compared to sham rats (n=3), myocardial ischemia-reperfusion (MIR group, n=5) induced a
significant increase in the myocardial content of MDA, a marker of lipid peroxidation, as
illustrated in Fig. 5A. This increase was suppressed by treatment with MnTBAP (MIR/
MnTBAP group, n = 5), confirming that the latter prevented the development of oxidative
stress in the reperfused myocardium. A further consequence of reperfusion was the large rise
of myocardial MPO activity, an indicator of neutrophil infiltration (Fig. 5B), an increase
significantly blunted by treatment with MnTBAP.
Ischemia-reperfusion induces the formation of nitrotyrosine in the myocardium,
which is alleviated by MnTBAP—Myocardial samples obtained from sham rats disclosed
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the presence in low amounts of nitrated proteins of approximately 25–30 kDa as shown in Fig.
5C. Following ischemia-reperfusion, a marked increase in the formation of nitrotyrosine (3-
NT) was noted, with several major bands located at 45–50 and 25–30 kDa, which were
markedly reduced by treatment with MnTBAP. In fact, as indicated by densitometric analysis,
while ischemia-reperfusion significantly increased 3-NT formation within the myocardium,
there was no statistically significant difference in the amount of nitrated proteins in the heart
of sham rats and ischemia-reperfusion rats treated with MnTBAP (Fig. 5D).
MnTBAP suppresses the cleavage of caspase-3 and PARP in the reperfused
myocardium—Ischemia followed by reperfusion of the myocardium (MIR group, n=8)
induced a marked activation of caspase-3, as indicated by a 17-fold increase of the ratio between
cleaved caspase-3 and procaspase-3 (Fig. 6A), associated with a 3.5 increase in the ratio of
cleaved PARP to full-length PARP (Fig. 6B), when compared to sham rats (n=6), indicating
that reperfusion elicited a significant activation of apoptotic pathways in the myocardium.
Scavenging of ONOO− with MnTBAP (MIR/MnTBAP group, n=9) suppressed the cleavage
of both caspase-3 and PARP, as illustrated by densitometric analysis of the immunoblot signals.
Discussion
Myocardial generation of ONOO− represents an important pathophysiological process in
conditions as various as myocardial infarction [2,32], heart failure [33], and cardiomyopathy
associated with sepsis [34,35], diabetes [36], and anthracycline therapy [37,38]. In such
conditions, ONOO− plays key roles in the development of myocardial mechanical dysfunction
through mechanisms involving the activation of matrix metalloproteinase 2 (MMP-2) [4], the
impairment of mitochondrial high-energy phosphate generation [39], the nitration of α-actinin
[5], the inactivation of myofibrillar creatine kinase [40], and the inactivation of CaATPase via
the nitration of SERCA2a [41]. Furthermore, ONOO− has been shown to represent an important
trigger of myocardial necrosis, by inducing oxidative DNA damage leading to the activation
of the DNA repair enzyme PARP, which consumes cellular NAD+, ultimately leading to ATP
depletion and necrotic cell death [9,42].
In the present study, we provide the novel evidence that ONOO− also produces an alternate
mode of cardiomyocyte cell death which presents all the characteristics of apoptosis, as
indicated by DNA fragmentation (Fig. 1D), the development of apoptotic nuclear
morphological alterations (Fig. 2), and the proteolytic activation of caspase-3 and the cleavage
of PARP (Fig. 3). In fact, apoptosis, rather than necrosis, appeared as the preferential mode of
cardiomyocyte death elicited by ONOO−in the conditions of this study, as ONOO− evoked a
large increase in the markers of apoptosis, but only a modest increase of biological indicators
of necrotic cell death (PI staining and LDH release, Figs. 1C and 2). Although a previous study
indicated that ONOO− could induce apoptosis in neonatal and adult rat ventricular myocytes
through a mechanism involving an increase in the proapoptotic protein Bax [17], our
observation that ONOO− triggers PARP cleavage has not been previously reported. It must be
stressed that PARP activation and PARP cleavage are fundamentally distinct events, linked to
completely different modes of cell demise, that is, either necrotic or apoptotic. The cleavage
of PARP into 89- and 24-kDa fragments inactivates the enzyme by destroying its ability to
respond to DNA strand breaks, thereby preventing the loss of cellular ATP associated with
PARP activation and maintaining the cellular energy essential for the execution of apoptosis
[43,44]. As such, PARP cleavage functions as a molecular switch between apoptotic and
necrotic modes of cell death [14]. Our observations clearly indicate that ONOO−should not be
solely regarded as a trigger of PARP activation, but also a potent inducer of the cleavage of
this important regulator of cell death in cardiac muscle cells.
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In support of our in vitro findings, we identified ONOO− generation as an important mechanism
activating proapoptotic signaling cascades in the heart during myocardial ischemia-reperfusion
in vivo. MIR was associated with significant oxidative stress (enhanced levels of
malondialdehyde, Fig. 5A), together with the generation of nitrotyrosine (Figs. 5C and 5D),
an indirect marker of nitrative stress and more specifically ONOO− generation [45,46], in the
myocardium, in agreement with previously published data [11,47–49]. These changes were
accompanied by significant cardiomyocyte apoptosis, as evidenced by the appearance of
cleavage fragments of both caspase-3 (Fig. 6A) and PARP (Fig. 6B) in myocardial samples
obtained from the reperfused left ventricle. Treatment with MnTBAP significantly reduced
MDA formation and nitrotyrosine generation, implying that this compound efficiently
alleviated ONOO− mediated oxidative stress in the myocardium. In parallel, a remarkable
effect of MnTBAP was the suppression of the cleavage of both caspase-3 and PARP, associated
with a considerable prevention of myocardial injury, as shown by the large reduction of infarct
size provided by MnTBAP (Fig. 4). It is here noteworthy that a previous experimental study
also reported a marked reduction of infarct size in rats treated with the peroxynitrite
decomposition catalyst FP15 [37]. Overall, these data imply that ONOO− dependent oxidant
stress is instrumental in activating proapoptotic signals (caspase-3 and PARP cleavage) in the
infarcted heart. Most probably, PARP cleavage consecutive to ONOO− generation was
secondary to the activation of caspase-3, but additional mechanisms may have been implicated
as well. Notably, a recent study has demonstrated that PARP can be cleaved in the nucleus of
cardiomyocytes through the action of MMP-2 [50], known to be activated by ONOO− [4].
Whether this pathway also takes place in vivo will require further investigations.
It is important to note that apoptosis has been recently proven to represent a dominant form of
cardiomyocyte death in ischemia-reperfusion, and myocardial apoptosis has been suggested
as the initiating factor of postinfarction left-ventricular remodeling (see [15,16] for review).
Although oxidants and free radicals are considered important triggers of myocardial apoptosis
in such conditions, the exact apoptotic stimulus still remains elusive [16]. Furthermore,
apoptosis is also critically involved in the cardiac damage associated with anthracycline
therapy, diabetes, sepsis, and dilated cardiomyopathy [16], which are all associated with an
enhanced generation of ONOO− within the myocardium [3]. On the basis of our findings, we
propose that ONOO− may represent a major oxidant species involved in the process of
cardiomyocyte apoptosis in these cardiac diseases, and that the beneficial effects of anti-
ONOO− therapies reported in these conditions might be related to the prevention of
cardiomyocyte apoptosis, an issue which should be critically investigated in future studies.
In addition to its effects on caspase-3 and PARP cleavage, MnTBAP also markedly reduced
the myocardial accumulation of polymorphonuclear cells (Fig. 5B), as attested by the
significant reduction of cardiac MPO activity, an effect that certainly contributed to a large
extent to reduce cardiac injury. Indeed, phagocyte infiltration has been proposed as a key
mechanism triggering postreperfusion cardiac damage [49]. These results imply a causative
role of ONOO− on the sequestration of neutrophils within the reperfused myocardium. This
hypothesis is supported by previous experimental evidence indicating that ONOO− favors
neutrophil-endothelial interactions by inducing acute endothelial damage and dysfunction
[51,52], and by enhancing the expression of various adhesion molecules [53,54]. Although not
directly tested in the present work, the marked effect of MnTBAP on MPO activity suggests
that similar mechanisms were set in motion by ONOO− in the myocardium exposed to ischemia
and reperfusion.
In summary, our data demonstrate that ONOO− triggers the activation of caspase-3 and the
cleavage of PARP both in cardiomyocytes in vitro and in the reperfused myocardium in vivo.
These results contrast with the usual paradigm that ONOO− is essentially an inducer of cell
necrosis through PARP activation, and provide novel information on the mechanisms of
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ONOO− dependent cytotoxicity in the heart. Since ONOO− is formed in many different cardiac
pathologies, in which apoptotic cell death is an important mechanism of myocyte loss, our
results support the assertion that ONOO− may be instrumental in the development of apoptosis
in such conditions.
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Abbreviations
MIR  
myocardial ischemia-reperfusion
PARP  
poly(ADP-ribose) polymerase
MnTBAP  
Mn(III)-tetrakis(4-benzoic acid) porphyrin
DMEM  
Dulbecco’s modified Eagle’s medium
FBS  
fetal bovine serum
MTT  
3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
PMSF  
phenylmethylsulfonyl fluoride
SDS-PAGE  
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
PI  
propidium iodide
AAR  
area at risk
TTC  
triphenyltetrazolium chloride
MPO  
myeloperoxidase assay
3-NT  
3-nitrotyrosine
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Fig. 1.
Cytotoxicity of ONOO− in H9C2 cells. (A,B) H9C2 cells were exposed to authentic
ONOO− (50–500 μM) or decomposed ONOO− (DP) for 20 min and then placed in complete
medium for 4 (A) or 6 h (B). Cell viability was determined by the MTT assay, and is expressed
in percentage of control, unstimulated cells (NS). While DP had no effect, ONOO− significantly
reduced cell viability at 4 and 6 h. (C,D) H9C2 cells were exposed to ONOO− or DP for 20
min and then observed for 6 h. LDH release in the medium was measured as an index of cell
necrosis. Apoptotic DNA fragmentation was quantified by a specific ELISA (see Materials
and methods). ONOO− elicited a modest, but significant increase in LDH release (expressed
in fold augmentation with respect to control cells), only at 250 and 500 μM (C). ONOO− at all
concentrations induced a significant increase in DNA fragmentation, expressed in percentage
of control cells (D). Decomposed ONOO− (DP) did not induce LDH release and DNA
fragmentation. Data are means±SE of n=5–6 determinations per condition. *P<0.05 vs. NS
(ANOVA followed by the Dunnett test).
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Fig. 2.
Typical apoptotic nuclear morphologic changes are induced by ONOO− in H9C2 cells. Cells
were treated with ONOO− for 20 min and then placed in complete medium for 6 h. Cells were
stained with Hoechst 33342 and PI to examine nuclear morphology. ONOO− (but not
decomposed ONOO−, DP) induced morphological changes characteristic of apoptosis
(chromatin condensation and nuclear shrinkage) at all concentrations, most notably at 250 and
500 μM, as indicated by the arrows. Only a small number of cells disclosed intact nuclei and
positive PI staining, indicative of primary cell necrosis (large arrow), whereas several cells
with apoptotic nuclei were also stained with PI, indicating late apoptosis or secondary necrosis
(arrowheads).
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Fig. 3.
ONOO− activates caspase-3 and triggers the cleavage of PARP in H9C2 cells. Immunoblot
detection of procaspase 3 and cleaved caspase-3 (left), full-length and cleaved PARP (right)
in cells stimulated with the indicated concentrations of ONOO−, or decomposed ONOO− (DP)
for 20 min, and placed in medium for 4 or 6 h. Caspase-3 was markedly cleaved in response
to ONOO− at all concentrations, but not DP, both at 4 and 6 h. ONOO−, but not DP also triggered
PARP cleavage at 100–500 μM after 4 h and at all concentrations after 6 h, as evidenced by
an increased signal for cleaved PARP associated to a reduced expression of full-length PARP.
The blots are representative of at least 3 independent experiments.
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Fig. 4.
The ONOO− scavenger MnTBAP reduces infarct size in the rat. (A) Area at risk (AAR) and
infarct size (expressed in % of AAR or % of left ventricle, LV) in rats exposed to 45 min LAD
occlusion followed by 2 h reperfusion. Rats were treated with either MnTBAP (MIR/
MnTBAP) or vehicle only (MIR). While AAR was comparable in both groups, there was a
significant reduction in infarct size in rats treated with MnTBAP. Means±SE of n=7–8 rats/
group. *P<0.05, unpaired t test. (B) Representative sections (mid-left ventricle) of reperfused
hearts stained with Evans blue/TTC showing reduced infarct size produced by MnTBAP.
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Fig. 5.
MnTBAP reduces MDA formation and MPO accumulation, and suppresses 3-nitrotyrosine
formation in myocardial ischemia-reperfusion. Cardiac MDA formation (A), an index of lipid
peroxidation, and MPO activity (B) in sham rats (n=3) or in rats exposed to myocardial
ischemia-reperfusion, treated with MnTBAP (MIR/MnTBAP group, n=5) or saline only (MIR
group, n=5). MIR induced significant increases of both MDA and MPO, which were
significantly reduced by MnTBAP. MDA and MPO were not significantly different between
sham rats and MIR/MnTBAP rats. (C) Representative Western blots of 3-nitrotyrosine (3-NT)
within myocardial samples obtained from the three groups of rats (n=4 rats/group). Molecular
weight markers are indicated on the left. (D) Densitometric analysis shows that MnTBAP
significantly prevented 3-NT formation upon myocardial reperfusion. There was no significant
difference between sham and MIR/MnTBAP rats. Means±SE. *P<0.05 (ANOVA followed by
Bonferroni).
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Fig. 6.
MnTBAP prevents the myocardial cleavage of caspase-3 and PARP during myocardial
infarction. Representative Western blots of procaspase 3 and cleaved caspase-3 (A), and of
full-length and cleaved PARP (B), in myocardial tissue of sham rats and rats exposed to
myocardial ischemia-reperfusion, treated with MnTBAP (MIR/MnTBAP) or saline (MIR).
The bar graphs show densitometric analysis of the blots, revealing a significant reduction of
the cleavage of caspase-3 and PARP in hearts from rats treated with MnTBAP. There was no
significant difference between sham and MIR/MnTBAP rats Means±SE of n=6–9 rats/group.
*P<0.05 (ANOVA followed by Bonferroni).
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